Victor W. van Beusechem
Technik-/Wissenschafts-/F&E-Leiter bei ORCA Therapeutics BV
Profil
Victor W.
van Beusechem is currently the Chief Scientific Officer at ORCA Therapeutics BV.
Previously, he worked as a Senior Scientist at Introgene BV and Janssen Vaccines & Prevention BV.
He holds a doctorate degree from the University of Leiden and an undergraduate degree from Vrije Universiteit Amsterdam.
Aktive Positionen von Victor W. van Beusechem
| Unternehmen | Position | Beginn |
|---|---|---|
ORCA Therapeutics BV
 ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Victor W. van Beusechem
| Unternehmen | Position | Ende |
|---|---|---|
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
| Introgene BV | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
Ausbildung von Victor W. van Beusechem
| University of Leiden | Doctorate Degree |
| Vrije Universiteit Amsterdam | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
| Introgene BV | Health Technology |
